Clinical Trial Update: Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trial 016.0012 [Phase 3]

View source ↗

Summary

This update reports an open-label extension for participants in a Phase 3 etanercept (TNFR:Fc) trial for rheumatoid arthritis, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2010-12-08